Special Session on Overseas Promotion of Chinese Time-Honored Brands (Guangzhou Pharmaceutical Holdings Limited Session) Successfully Held at the 22nd World Congress of Chinese Medicine Sub-Forum

(Sydney, Australia) On the morning of October 31st local time, Special Session on Overseas Promotion of Chinese Time-Honored Brands (Guangzhou Pharmaceutical Group Session), themed  Innovative Development of Chinese Medicine Time-Honored Brands and Research on the Internationalization Strategy of Guangzhou Pharmaceutical Holdings Limited", was successfully held at the Sydney International Convention Centre as part of the 22nd World Congress of Chinese Medicine. The event was hosted by the Chinese Medicine Chinese Time-Honored Brands Collaborative Innovation Center and organized by China Guangzhou Pharmaceutical Holdings Limited (GPHL). Max Ma, President of Chinese Medicine Industry Council of Australia , and Li Yu, Vice Chairman and Secretary-General of the World Federation of Chinese Medicine Societies (WFCMS), delivered opening speeches. Wang Jing, Director of the International Liaison Department of WFCMS, presided over the opening ceremony.

The World Federation of Chinese Medicine Societies was selected by the Chinese Ministry of Commerce in September 2024 as a construction unit for the second batch of "Time-Honored Brands Collaborative Innovation Centers". Seizing this opportunity, WFCMS has been actively integrating resources to build a professional platform dedicated to serving the international development of Chinese medicine time-honored brands. As a major science-industrial-trade integrated enterprise under key support from Guangzhou City, GPHL boasts a portfolio of 13 time-honored brands with profound heritage, including Wanglaoji, Chenliji, Jingxiutang, Pangaoshou, Caizhilin, Zhongyi Pharmaceutical, Xingqun Pharmaceutical, Qixing Pharmaceutical, Guanghua Pharmaceutical, Hejigong, Mingxing Pharmaceutical, Jianmin Chain, and Caishantang, many of which have histories exceeding a century. To fulfill its duties as a construction unit and propel Chinese medicine time-honored brands to go global, WFCMS, in its capacity as the "Chinese Medicine Time-Honored Brand Collaborative Innovation Center" collaborated with GPHL to successfully organize this sub-forum event.

Li Yu, Vice Chairman and Secretary-General of the World Federation of Chinese Medicine Societies, Delivers Speech at the Special Session

In his speech, Li Yu stated that Chinese medicine time-honored brands are precious legacies of Chinese medical culture, with long histories and deep public trust. WFCMS has been actively promoting the establishment of China Time-honored Brand TCM Overseas Cultural Center in France and Australia. The revitalization of Chinese medicine relies on academic guidance and industrial support. Enterprises are the mainstay of technological innovation and the core force driving the modernization, industrialization, and internationalization of Chinese medicine. Outstanding Chinese medicine enterprises represented by GPHL are integrating traditional wisdom with modern technology to build nationally influential brands with global impact, guiding Chinese medicine along the "Belt and Road" to the world. Currently, promoting the high-quality development of the Chinese medicine industry is our shared responsibility of the times and mission for the future.

Max Ma, President of the Chinese Medicine Industry Council of Australia, delivers Speech at the Special Session

Li Xiaojun, Party Secretary and Chairman of Guangzhou Pharmaceutical Holdings Limited, delivers Speech at the Special Session

The event featured invited experts who delivered thematic lectures. Diane Wilkinson, Director of the Complementary and Over-the-Counter Medicines Branch, Business Improvement and Support Section, Therapeutic Goods Administration, Australian Government Department of Health and Aged Care, shared insights on "TGA Regulation of Chinese Medicines," providing policy guidance for the internationalization of Chinese medicine from a regulatory science perspective. Professor Luo Songping, Director of the Gynecology and Pediatrics Center at the First Affiliated Hospital of Guangzhou University of Chinese Medicine, gave a presentation titled "Continuous Innovation of Chinese Patent Medicines from the Research and Application of Zishen Yutai Pills" showcasing the innovative breakthroughs of classical formulations under modern scientific research.

**Director Diane Wilkinson Delivers Thematic Sharing**

Professor Luo Songping, delivers Thematic Sharing

Liu Hong, Deputy Director of the Science and Technology Management Department of GPHL; Fang Dafeng, General Manager of Guangzhou Wanglaoji Health Industry Co., Ltd.; Ning Na, General Manager of Guangzhou Baiyunshan ZHONGYI Pharmaceutical Company Limited and  concurrently Guangzhou Baiyunshan Qixing Pharmaceutical Co., Ltd.; and Yuan Cheng, Chairman of Guangzhou Hanfang Pharmaceutical Co., Ltd., delivered keynote speeches respectively on GPHL's scientific and technological innovation and development overview, Wanglaoji's internationalization strategy practices, Zhongyi Pharmaceutical's digital innovation practices in Chinese medicine, and Hanfang's modernization innovation practices in Chinese medicine. These presentations comprehensively demonstrated GPHL's exploration and achievements in the innovative development of Chinese medicine.

In the Panel Discussion on “The Application of Chinese Medicine in the Global Health Field”, Zhang Boli, recipient of the national honorary title "People's Hero," academician of the Chinese Academy of Engineering, Master of Chinese Medicine, and Vice Chairman of the World Federation of Chinese Medicine Societies; Zheng Qiming, Vice Chairman of the World Federation of Chinese Medicine Societies, Chairman of Philippine TCM and Acupuncture Association; Chen Wenfeng, Party Secretary of Guangzhou University of Chinese Medicine; Lian Zenglin, Vice Chairman of Centre France Chine de la Médecine Chinoise; and Li Xiaojun, Chairman of GPHL, engaged in in-depth dialogue and discussion on topics including the application of Chinese medicine in global health, the overseas expansion of Chinese medicine, and cross-cultural communication. The Discussion was hosted by Zheng Jianxiong, Deputy General Manager of GPHL Baiyunshan.

Academician Zhang Boli Speaks at the Panel Discussion

During the salon, Academician Zhang Boli pointed out that for Chinese medicine to go global, it is essential to maintain cultural confidence, base efforts on the domestic market, leverage the advantages of digital upgrades in domestic Chinese medicine enterprises, support international expansion with solid evidence and high quality, and position Chinese medicine as representing "high-end," "cutting-edge," and "advanced" qualities. Simultaneously, it is crucial to promote healthy and sustainable development, be guided by clinical needs, clarify effective substances, mechanisms of action, control drug hazards, strictly adhere to GMP standards in production, and enhance drug quality. In his speech, Academician Zhang Boli acknowledged GPHL's continuous improvement in product quality through digital transformation. Citing GPHL brand Ganoderma Lucidum Spore Oil Soft Capsules as an example, he emphasized that this product is a typical representative of the modernization and high quality of Chinese medicine.

 Zheng Qiming, Vice Chairman of the World Federation of Chinese Medicine Societies, Chairman of Philippine TCM and Acupuncture Association, Shares Insights at the Discussion

Lian Zenglin, Vice Chairman of Centre France Chine de la Médecine Chinoise, Shares Insights at the Salon

Li Xiaojun Speaks at the Thematic Salon

Zheng Jianxiong, Deputy General Manager of GPHL Baiyunshan, Hosts the Discussion

During the event, the Wanglaoji WALOVI International Can was officially launched in Sydney, marking another significant step in Wanglaoji's internationalization journey.

Wanglaoji WALOVI International Can Officially Launched in Sydney

Witnessed by numerous experts and scholars, GPHL signed strategic cooperation agreements with the China Time-honored Brand TCM Overseas Cultural Center (France) /Centre France Chine de la Médecine Chinoise (CFCMC);  Guangzhou Wanglaoji Health Industry Co., Ltd. signed with Australia's Valucky Company; and Chenliji signed with the University of Melbourne. These agreements cover multiple areas including cultural promotion, research and development cooperation, and market collaboration.

GPHL and China Time-honored Brand TCM Overseas Cultural Center (France) /Centre France Chine de la Médecine Chinoise (CFCMC) Complete Strategic Cooperation Signing

Guangzhou Wanglaoji Health Industry Co., Ltd. and Australia's Valucky Company Complete Strategic Cooperation Signing

Guangzhou Chenliji Pharmaceutical Factory Co. Ltd. and the University of Melbourne Complete Strategic Cooperation Signing